artificial intelligence machine

Smart AI Use Could Benefit Biopharma

Artificial intelligence has an important role in bioreactors and beyond if biopharma can work out how to use it on the factory floor.
Bio4c Process diagram

Digital Ecosystem Combines Process Control, Analytics, and Plant-Level Automation

Bioprocessing 4.0 depends on integrated software, and MilliporeSigma just rolled out a new option.
cancer cell

AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment

Deal covers the production of Clevegen, a humanized anti-Clever-1 antibody.
lab equipment

Streamlining High-Throughput Impurity Analysis in Process Development

REGISTER NOW Broadcast Date: June 4, 2020 Time: 8:00 am PT, 11:00 am ET, 17:00 CET In the biopharma industry, there currently is a need to increase production capacity to meet the analytical demands of process development...
Candida auris fungi, illustration

BIOPROCESSING 4.0: Advanced Monitoring Tech Trends in Production

Sartorius has long been a leader in bioprocessing and its expertise is clearly on display in this e-book, specifically in the company’s adoption of advanced monitoring techniques in bioproduction. Here you will read about how Sartorius uses state-of-the art biosensors to carry out critical monitoring procedures during bioreactor operations.
Coronavirus blood vials

Coronavirus Vaccine Race Approaching Quality Control Hurdle

COVID-19 has increased vaccine sector demand for contractors with next generation QC and formulation technologies.
Medical Vials and a Syringe - Vaccination Concepts Series

Hidden Costs of Single-Use Bioprocessing Technology

Taking a close look at the pros and cons of an increasingly popular biomanufacturing methodology.
Sartorius lab

Sartorius’ Acquisition of Danaher Techs Fits Demand for Process Intensification

Industry bioprocessing needs are diversifying, and the technology acquired from Danaher is intended to close the gaps.
Genetic engineering concept. Medical science. Scientific Laboratory.

Univercells Launches New Bioprocess Subsidiary

Company wants to boost its market reach to support advances in cell and gene therapy manufacturing.

Genome Editing Helps Cell Lines “Clean Up” Their Protein Production

The mammalian cell lines that are engineered to produce high-value recombinant-protein drugs also produce unwanted proteins that reduce drug quality and increase production costs. Researchers have now introduced a CRISPR-Cas9 genome-editing technique that can eliminate up to 70% of the contaminating protein by mass in recombinant-protein drugs produced by CHO cells, workhorses of biotherapeutic protein production.

Recently Featured

Scroll Up